Navigation Links
American Peptide Company Expands Their Large Scale cGMP Synthesis Capabilities
Date:8/26/2013

Sunnyvale, CA (PRWEB) August 26, 2013

American Peptide Company (APC) announces the expansion of their large scale cGMP peptide synthesis capabilities with the addition of a 300 Liter solid phase synthesis reactor and a 294 Liter tray lyophilizer.

American Peptide’s state of the art 35,000 square foot cGMP facility is located in Vista, California. The 300 Liter solid phase synthesis reactor is one of the largest in the U.S. peptide CMO industry. The 294 Liter tray lyophilizer has 15 square meters of shelf space and is the largest in the peptide CMO industry. Two additional 50 Liter tray lyophilizers have also been recently added to their cGMP facility.

The 294 Liter tray lyophilizer is equipped with a Clean In Place (CIP) skid to eliminate cross contamination between batches. The temperature of each step is controlled, and the conductivity of the water is monitored. The control system includes full PLC automation with 21 CFR parts 210, 211 compliant operation and a well-documented SOP.

These new pieces of equipment are complimented by an existing array of synthesis reactors, lyophilizers and large scale purification columns.

With the expansion of their large scale cGMP synthesis capacity, American Peptide Company can produce multi-kilograms of active pharmaceutical ingredients in individual batches. Large scale peptide synthesis helps make the process more economical and shortens delivery times.

###

About American Peptide Company, Inc.
American Peptide Company (APC) is a leading manufacturer of peptides and peptide conjugates. The company offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide active pharmaceutical ingredients (APIs). Our California based manufacturing facilities offer synthesis services under Non GMP (Sunnyvale, California) and cGMP (Vista, California) conditions. Our cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A. Our Total Peptide Management services support clients in the drug development process from pre-clinical thru commercial stage. Our value added services include process development, scale up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.

For more information, please visit http://www.americanpeptide.com.

Read the full story at http://www.prweb.com/releases/peptide/synthesis/prweb11055041.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Zane Benefits Publishes New Information on How Many Americans will Qualify for Premium Tax Credits
2. Inc. Magazine Names AvePoint to the Inc. 500
3. 5000 List of Fastest Growing American Companies for the Fourth Consecutive Year
4. Kenneth Bernstein, M.D., receives Distinguished Scientist designation from American Heart Association
5. American Farmer Announces Upcoming Episode on Maple Syrup Production to Air on RFD-TV
6. American Society for Aesthetic Plastic Surgery Advises Consumers to Avoid Unqualified Personnel Performing Cosmetic Procedures
7. American Scientists Attempt to Sequence John Lennon's Genetic Code from the Beatle's Tooth
8. Journal of the American College of Cardiology Taps Next Editor-in-Chief
9. Experiences of racism linked to adult-onset asthma in African-American women
10. Stroke declines dramatically, still higher in Mexican Americans
11. Vaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Litigation for American Medical Systems Mesh Lawsuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported ... , “This was our first franchise-wide Quack Gives Back initiative, and ...
(Date:12/8/2016)... ... 08, 2016 , ... Mirixa Corporation , a leading ... pharmacist-delivered patient care services, has announced the promotions of Karen Litsinger to senior ... of sales. , Litsinger joined Mirixa in 2008 after serving as a ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016 aTyr Pharma, Inc. (Nasdaq: ... development of Physiocrine-based therapeutics to address severe, rare diseases, today announced ... upcoming BMO Prescriptions for Success Healthcare Conference at the InterContinental Barclay ... December 14, 2016, at 4:20 p.m. ET. About ... ...
(Date:12/9/2016)... , Dec. 9, 2016 Department of Health ... regulations for medical marijuana dispensaries under Act 16 are ... , and are now available online . ... in the plan for operation; process for dispensing medical ... well as where the dispensary facilities can be located," ...
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
Breaking Medicine Technology: